Clinical Trial

Efficacy and Safety of Trifluridine/Tipiracil Combined With Fufuquitinib for Third-line Treatment of mCRC

Unknown Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated July 3, 2024 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
To evaluate the efficacy and safety of trifluridine/tipiracil combined with fufuquitinib versus trifluridine/tipiracil and fufuquitinib in patients with unresectable metastatic colorectal cancer.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06485713
Lead Sponsor First Affiliated Hospital of Wenzhou Medical University
Conditions Metastatic Colorectal Cancer, Drug Therapy
Enrollment 200 participants
Start Date 2024-03-01
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2024-07-03